Hypoxia-inducible factor 1-induced G protein-coupled receptor 35 expression is an early marker of progressive cardiac remodelling

Cardiovascular Research

Volumn 101, Issue 1, 2014, Pages 69-77

  Ronkainen, Veli Pekka ^a   Tuomainen, Tomi ^b   Huusko, Jenni ^b   Laidinen, Svetlana ^b   Malinen, Marjo ^b   Palvimo, Jorma J ^b   Ylä Herttuala, Seppo ^b   Vuolteenaho, Olli ^a   Tavi, Pasi ^b  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

GPR35; HIF 1; Infarction; Pressure overload; Transcription

Indexed keywords

DEFEROXAMINE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 35; HYPOXIA INDUCIBLE FACTOR 1; PROTEIN VP16; UNCLASSIFIED DRUG; ZAPRINAST;

ACTIN FILAMENT; ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL DISRUPTION; CELL HYPOXIA; CELL MEMBRANE; CELL STRUCTURE; CONTROLLED STUDY; DISEASE MARKER; ECHOCARDIOGRAPHY; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; HEART CELL CULTURE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; INTERNALIZATION; LIGATION; MOUSE; MUTATION; MUTATIONAL ANALYSIS; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ULTRASOUND SCANNER;

GPR35; HIF-1; INFARCTION; PRESSURE OVERLOAD; TRANSCRIPTION;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIGANDS; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; OXYGEN; PROMOTER REGIONS, GENETIC; RECEPTORS, G-PROTEIN-COUPLED; VENTRICULAR REMODELING;

EID: 84891353643     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt226     Document Type: Article

References (32)

1. Fredriksson R, Schioth HB. The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol 2005;67:1414-1425.
2. O'Dowd BF, Nguyen T, Marchese A, Cheng R, Lynch KR, HengHHQ et al. Discovery of three novel G-protein-coupled receptor genes. Genomics 1998;47:310-313.
3. Forrest CM, Mackay GM, Oxford L, Stoy N, Stone TW, Darlington LG. Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment. Clin Exper Pharmacol Physiol 2006;33:1078-1087.
4. Oka S, Ota R, Shima M, Yamashita A, Sugiura T. GPR35 is a novel lysophosphatidic acid receptor. Biochem Biophys Res Commun 2010;395:232-237.
5. Taniguchi Y, Tonai-Kachi H, Shinjo K. Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35. FEBS Lett 2006;580:5003-5008.
6. Zhao P, Sharir H, Kapur A, Cowan A, Geller EB, AdlerMWet al. Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and beta-arrestin2 with antinociceptive activity. Mol Pharmacol 2010;78:560-568.
7. Yang Y, Lu JY,Wu X, Summer S, Whoriskey J, Saris C et al. G-Protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium. Pharmacology 2010;86:1-5.
8. Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H et al. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 2006;281: 22021-22028.
9. Ohshiro H, Tonai-Kachi H, Ichikawa K. GPR35 is a functional receptor in rat dorsal root ganglion neurons. Biochem Biophys Res Commun 2008;365:344-348.
10. Guo J, Williams DJ, Puhl HL III, Ikeda SR. Inhibition of N-type calcium channels by activation of GPR35, an orphan receptor, heterologously expressed in rat sympathetic neurons. J Pharmacol Exp Ther 2008;324:342-351.
11. Jenkins L, Brea J, Smith NJ, Hudson BD, Reilly G, Bryant NJ et al. Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of beta-arrestin-2 and activate G(alpha 13). Biochem J 2010;432:451-459.
12. Jenkins L, Alvarez-Curto E, Campbell K, de Munnik S, Canals M, Schlyer S et al. Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via G alpha(13) and beta-arrestin-2. Br J Pharmacol 2011;162: 733-748.
13. Min K, Asakura M, Liao Y, Nakamaru K, Okazaki H, Takahashi T et al. Identification of genes related to heart failure using global gene expression profiling of human failing myocardium. Biochem Biophys Res Commun 2010;393:55-60.
14. Sun YV, Bielak LE, Peyser PA, Turner ST, Sheedy PE II, Boerwinkle E et al. Application of machine learning algorithms to predict coronary artery calcification with a sibship-based design. Genet Epidemiol 2008;32:350-360.
15. Ronkainen VP, Ronkainen JJ, Hannninen SL, Leskinen H, Ruas JL, Pereira T et al. Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. Faseb J 2007;21: 1821-1830.
16. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A et al. HL-1 cells:Acardiacmuscle cell line that contractsand retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 1998;95:2979-2984.
17. Sahu B, Laakso M, Ovaska K, Mirtti T, Lundin J, Rannikko A et al. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. EMBO J 2011;30:3962-3976.
18. GaoE, Lei YH, Shang X, Huang ZM, Zuo L, BoucherMet al.Anovel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res 2010;107: 1445-1453.
19. Huusko J, Lottonen L, Merentie M, Gurzeler E, Anisimov A, Miyanohara A et al. AAV9-mediated VEGF-B Gene Transfer Improves Systolic Function in Progressive Left Ventricular Hypertrophy. Mol Ther 2012;20:2212-2221.
20. Huusko J, Merentie M, Dijkstra MH, Ryhanen MM, Karvinen H, Rissanen TT et al. The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice. Cardiovasc Res 2010;86:122-130.
21. Okumura S, Baba H, Kumada T, Nanmoku K, Nakajima H, Nakane Y et al. Cloning of a G-protein-coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells. Cancer Sci 2004;95:131-135.
22. Stenoien DL, Knyushko TV, Londono MP, Opresko LK, Mayer MU, Brady ST et al. Cellular trafficking of phospholamban and formation of functional sarcoplasmic reticulum during myocyte differentiation. Am J Physiol Cell Physiol 2007;292:C2084-C2094.
23. Baker DL, Desiderio DM, Miller DD, Tolley B, Tigyi GJ. Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry. Anal Biochem 2001;292:287-295.
24. Moolenaar WH. Bioactive lysophospholipids and their G protein-coupled receptors. Exp Cell Res 1999;253:230-238.
25. Li TT, Alemayehu M, Aziziyeh AI, Pape C, Pampillo M, Postovit L et al. Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells. Mol Cancer Res 2009;7:1064-1077.
26. Krishnan J, Suter M, Windak R, Krebs T, Felley A, Montessuit Cet al. Activation of a HIF1 alpha-PPAR gamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab 2009;9:512-524.
27. Jiang B, Semenza G, Bauer C, Marti H. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O-2 tension. Am J Physiol Cell Physiol 1996; 271:C1172-C1180.
28. Taniguchi Y, Tonai-Kachi H, Shinjo K. 5-Nitro-2-(3-phenylpropylamino) benzoic acid is a GPR35 agonist. Pharmacology 2008;82:245-249.
29. Buhl AM, Johnson NL, Dhanasekaran N, Johnson GL. G-Alpha(12) and G-alpha(13) stimulate rho-dependent stress fiber formation and focal adhesion assembly. J Biol Chem 1995;270:24631-24634.
30. Gohla A, Offermanns S, Wilkie TM, Schultz G. Differential involvement of G alpha(12) and G alpha(13) in receptor-mediated stress fiber formation. J Biol Chem 1999;274: 17901-17907.
31. Scott MGH, Pierotti V, Storez H, Lindberg E, Thuret A, Muntaner O et al. Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins. Mol Cell Biol 2006;26:3432-3445.
32. Shyu KG, Lu MJ, Chang H, Sun HY,WangBW, Kuan P. Carvedilol modulates the expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in a rat model of volume-overload heart failure. J Card Fail 2005;11:152-159.